Two companies have received approved for a generic of the 2.5 mg tablet of anticoagulant rivaroxaban, which is used to reduce ...

The Food and Drug Administration (FDA) has approved the first generics of Xarelto ® (rivaroxaban) 2.5mg. Xarelto 2.5mg is used, in combination with aspirin, to: Reduce the risk of major cardiovascular ...

Lupin is introducing rivaroxaban tablets, 2.5 mg, which is the generic of Janssen’s Xarelto. The medication is used to reduce the risk of major cardiovascular events in patients with coronary ...

Drug firm Lupin Ltd on Friday (March 7) said it has launched rivaroxaban tablets USP, 2.5 mg, in the US market following final approval from the US Food and Drug Administration (FDA) for its ...

Lupin has launched Rivaroxaban Tablets USP, 2.5 mg, following the final approval of its Abbreviated New Drug Application from the U.S. FDA. Rivaroxaban Tablets USP, 2.5 mg, is bioequivalent to Xarelto ...

Patients were randomized in a 1:1:1 ratio to receive either subcutaneous abelacimab at 90 mg or 150 mg once monthly or oral rivaroxaban 20mg once daily (15 mg for patients with creatinine clearance ...

In patients undergoing upper gastrointestinal endoscopic submucosal dissection, risk for ischemic stroke was lower with rivaroxaban than with dabigatran. Rivaroxaban was associated with a lower risk ...

The FDA approved the first generics of the direct oral anticoagulant rivaroxaban, the agency announced on Tuesday. Rivaroxaban 2.5 mg tablets from Lupin and Taro are now considered therapeutic ...

If your child is still experiencing symptoms, their doctor may increase the dosage to a maximum of 20 mg once per day. They’ll do this by slowly increasing the daily dose by 5 mg once per week.

X-VErT enrolled around 1,500 patients who were assigned to either Xarelto 20mg once-daily or a VKA (mainly warfarin) and found that compared to patients treated with Bayer and Janssen's drug had a ...